Intercept Pharmaceuticals Inc RPE
What is the RPE of Intercept Pharmaceuticals Inc?
The RPE of Intercept Pharmaceuticals Inc is $572.411k
What is the definition of RPE?
Revenue per employee (RPE) is revenue divided by the number of employees of an organization.
= net income / number of employees
RPE of companies in the Health Care sector on NASDAQ compared to Intercept Pharmaceuticals Inc
What does Intercept Pharmaceuticals Inc do?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Companies with rpe similar to Intercept Pharmaceuticals Inc
- Credit Suisse AG has RPE of CHF571.932k
- Avery Dennison has RPE of $571.959k
- Tejon Ranch Co has RPE of $572.043k
- REA has RPE of AUD$572.160k
- Banco Bilbao Vizcaya Argentaria S.A has RPE of €572.189k
- Ryder System has RPE of $572.291k
- Intercept Pharmaceuticals Inc has RPE of $572.411k
- Shinelong Automotive has RPE of ¥572.799k
- Ranpak Corp has RPE of $572.924k
- Five Below Inc has RPE of $572.938k
- Atari SA has RPE of €573.077k
- Enterprise Services has RPE of $573.112k
- Commonwealth Bank of Australia has RPE of AUD$573.116k